The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Classification criteria for psoriatic arthritis: Development of new criteria from a large international study
Abstract
Objective: To compare the accuracy of existing classification criteria for the diagnosis of psoriatic arthritis (PsA) and to construct new criteria from observed data. Methods: Data were collected prospectively from consecutive clinic attendees with PsA and other inflammatory arthropathies. Subjects were classified by each of 7 criteria. Sensitivity and specificity were compared using conditional logistic regression analysis. Latent class analysis was used to calculate criteria accuracy in order to confirm the validity of clinical diagnosis as the gold standard definition of “case”‐ness. Classification and Regression Trees methodology and logistic regression were used to identify items for new criteria, which were then constructed using a receiver operating characteristic curve. Results: Data were collected on 588 cases and 536 controls with rheumatoid arthritis (n = 384), ankylosing spondylitis (n = 72), undifferentiated arthritis (n = 38), connective tissue disorders (n = 14), and other diseases (n = 28). The specificity of each set of criteria was high. The sensitivity of the Vasey and Espinoza method (0.97) was similar to that of the method of McGonagle et al (0.98) and greater than that of the methods of Bennett (0.44), Moll and Wright (0.91), the European Spondylarthropathy Study Group (0.74), and Gladman et al (0.91). The CASPAR (ClASsification criteria for Psoriatic ARthritis) criteria consisted of established inflammatory articular disease with at least 3 points from the following features: current psoriasis (assigned a score of 2; all other features were assigned a score of 1), a history of psoriasis (unless current psoriasis was present), a family history of psoriasis (unless current psoriasis was present or there was a history of psoriasis), dactylitis, juxtaarticular new bone formation, rheumatoid factor negativity, and nail dystrophy. These criteria were more specific (0.987 versus 0.960) but less sensitive (0.914 versus 0.972) than those of Vasey and Espinoza. Conclusion: The CASPAR criteria are simple and highly specific but less sensitive than the Vasey and Espinoza criteria.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Classification and Regression Trees.
Gordon, A. D., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1984) · Biometrics · doi:10.2307/2530946 · Cited by 23,522
Classification and Regression Trees.
Ryzin, J. V., Breiman, L., Friedman, J. H., Olshen, R. A., & Stone, C. J. (1986) · Journal of the American Statistical Association · doi:10.2307/2288003 · Cited by 20,825
Measurement of patient outcome in arthritis
Fries, J. F., Spitz, P., Kraines, R. G., & Holman, H. R. (1980) · Arthritis & Rheumatism · doi:10.1002/art.1780230202 · Cited by 4,382
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Dougados, M., Linden, S. V. D., Juhlin, R., Huitfeldt, B., Amor, B., Calin, A., Cats, A., Dijkmans, B., Olivieri, I., Pasero, G., et al. (1991) · Arthritis & Rheumatism · doi:10.1002/art.1780341003 · Cited by 2,299
Moll, J. M. H., & Wright, V. (1973) · Seminars in Arthritis and Rheumatism · doi:10.1016/0049-0172(73)90035-8 · Cited by 1,261
Psoriatic Arthritis (PSA) - An Analysis of 220 Patients
(1987) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068085 · Cited by 639
CART (Classification and Regression Trees)
(2004) · The SAGE Encyclopedia of Social Science Research Methods · doi:10.4135/9781412950589.n88 · Cited by 430
Psoriatic arthritis: A unified concept twenty years on
McGonagle, D., Conaghan, P. G., & Emery, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199906)42:6<1080::aid-anr2>3.0.co;2-7 · Cited by 301
Classification and diagnostic criteria for psoriatic arthritis
Helliwell, P., & Taylor, W. J. (2005) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2004.032318 · Cited by 290
Self-citation
Cited by
Rudwaleit, M., van der Heijde, D., Landewé, R., Akkoc, N., Brandt, J., Chou, C. T., Dougados, M., Huang, F., Gu, J., Kirazli, Y., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.133645 · Cited by 1,768
Ritchlin, C. T., Colbert, R. A., & Gladman, D. D. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1505557 · Cited by 1,404
Self-citationGreb, J. E., Goldminz, A. M., Elder, J. T., Lebwohl, M. G., Gladman, D. D., Wu, J. J., Mehta, N. N., Finlay, A. Y., & Gottlieb, A. B. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.82 · Cited by 922
Self-citationCoates, L. C., Kavanaugh, A., Mease, P. J., Soriano, E. R., Laura Acosta‐Felquer, M., Armstrong, A. W., Bautista‐Molano, W., Boehncke, W., Campbell, W., Cauli, A., et al. (2016) · Arthritis & Rheumatology · doi:10.1002/art.39573 · Cited by 903
Self-citationScher, J. U., Ubeda, C., Artacho, A., Attur, M., Isaac, S., Reddy, S. M., Marmon, S., Neimann, A., Brusca, S., Patel, T., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.38892 · Cited by 815
Guidelines of care for the management of psoriasis and psoriatic arthritis
Gottlieb, A., Korman, N. J., Gordon, K. B., Feldman, S. R., Lebwohl, M., Koo, J. Y. M., Van Voorhees, A. S., Elmets, C. A., Leonardi, C. L., Beutner, K. R., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.02.040 · Cited by 769
Secukinumab Inhibition of Interleukin-17A in Patients with Psoriatic Arthritis
Mease, P. J., McInnes, I. B., Kirkham, B., Kavanaugh, A., Rahman, P., van der Heijde, D., Landewé, R., Nash, P., Pricop, L., Yuan, J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1412679 · Cited by 746
Self-citationPrevalence of metabolic syndrome in patients with psoriasis: a hospital-based case?control study
Gisondi, P., Tessari, G., Conti, A., Piaserico, S., Schianchi, S., Peserico, A., Giannetti, A., & Girolomoni, G. (2007) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2007.07986.x · Cited by 675
Alinaghi, F., Calov, M., Kristensen, L. E., Gladman, D. D., Coates, L. C., Jullien, D., Gottlieb, A. B., Gisondi, P., Wu, J. J., Thyssen, J. P., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.06.027 · Cited by 673
Self-citationRitchlin, C., Rahman, P., Kavanaugh, A., McInnes, I. B., Puig, L., Li, S., Wang, Y., Shen, Y.-K., Doyle, M. K., Mendelsohn, A. M., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204655 · Cited by 662
Furer, V., Eviatar, T., Zisman, D., Peleg, H., Paran, D., Levartovsky, D., Zisapel, M., Elalouf, O., Kaufman, I., Meidan, R., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220647 · Cited by 654
Crowson, C. S., Matteson, E. L., Myasoedova, E., Michet, C. J., Ernste, F. C., Warrington, K. J., Davis, J. M., Hunder, G. G., Therneau, T. M., & Gabriel, S. E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30155 · Cited by 638
Wilson, F. C., Icen, M., Crowson, C. S., McEvoy, M. T., Gabriel, S. E., & Kremers, H. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24172 · Cited by 605
Mease, P. J., van der Heijde, D., Ritchlin, C. T., Okada, M., Cuchacovich, R. S., Shuler, C. L., Lin, C.-Y., Braun, D. K., Lee, C. H., & Gladman, D. D. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-209709 · Cited by 580
Self-citationTofacitinib or Adalimumab versus Placebo for Psoriatic Arthritis
Mease, P., Hall, S., FitzGerald, O., van der Heijde, D., Merola, J. F., Avila-Zapata, F., Cieślak, D., Graham, D., Wang, C., Menon, S., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615975 · Cited by 571
Self-citationTreatment recommendations for psoriatic arthritis
Ritchlin, C. T., Kavanaugh, A., Gladman, D. D., Mease, P. J., Helliwell, P., Boehncke, W.-H., de Vlam, K., Fiorentino, D., FitzGerald, O., Gottlieb, A. B., et al. (2009) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.094946 · Cited by 554
Self-citationGeoepidemiology and environmental factors of psoriasis and psoriatic arthritis
Chandran, V., & Raychaudhuri, S. P. (2010) · Journal of Autoimmunity · doi:10.1016/j.jaut.2009.12.001 · Cited by 510
Tofacitinib for Psoriatic Arthritis in Patients with an Inadequate Response to TNF Inhibitors
Gladman, D., Rigby, W., Azevedo, V. F., Behrens, F., Blanco, R., Kaszuba, A., Kudlacz, E., Wang, C., Menon, S., Hendrikx, T., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615977 · Cited by 510
Self-citationThe Epidemiology of Psoriatic Arthritis
Ogdie, A., & Weiss, P. (2015) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2015.07.001 · Cited by 506
Elmets, C. A., Leonardi, C. L., Davis, D. M. R., Gelfand, J. M., Lichten, J., Mehta, N. N., Armstrong, A. W., Connor, C., Cordoro, K. M., Elewski, B. E., et al. (2019) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.11.058 · Cited by 503
Smolen, J. S., Braun, J., Dougados, M., Emery, P., FitzGerald, O., Helliwell, P., Kavanaugh, A., Kvien, T. K., Landewé, R., Luger, T., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-203419 · Cited by 447
Self-citationKimball, A. B., Gladman, D., Gelfand, J. M., Gordon, K., Horn, E. J., Korman, N. J., Korver, G., Krueger, G. G., Strober, B. E., & Lebwohl, M. G. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2008.01.006 · Cited by 432
Self-citationGossec, L., de Wit, M., Kiltz, U., Braun, J., Kalyoncu, U., Scrivo, R., Maccarone, M., Carton, L., Otsa, K., Sooäär, I., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-205207 · Cited by 413
Self-citationNash, P., Kirkham, B., Okada, M., Rahman, P., Combe, B., Burmester, G.-R., Adams, D. H., Kerr, L., Lee, C., Shuler, C. L., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31429-0 · Cited by 405
Self-citationBrodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis
Mease, P. J., Genovese, M. C., Greenwald, M. W., Ritchlin, C. T., Beaulieu, A. D., Deodhar, A., Newmark, R., Feng, J., Erondu, N., & Nirula, A. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315231 · Cited by 395
Self-citationPreventing psoriatic arthritis: focusing on patients with psoriasis at increased risk of transition
Scher, J. U., Ogdie, A., Merola, J. F., & Ritchlin, C. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-019-0175-0 · Cited by 394
Psoriasis: classical and emerging comorbidities
Oliveira, M. D. F. S. P. D., Rocha, B. D. O., & Duarte, G. V. (2015) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20153038 · Cited by 374
Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis
Hüffmeier, U., Uebe, S., Ekici, A. B., Bowes, J., Giardina, E., Korendowych, E., Juneblad, K., Apel, M., McManus, R., Ho, P., et al. (2010) · Nature Genetics · doi:10.1038/ng.688 · Cited by 371
FitzGerald, O., Ogdie, A., Chandran, V., Coates, L. C., Kavanaugh, A., Tillett, W., Leung, Y. Y., deWit, M., Scher, J. U., & Mease, P. J. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00293-y · Cited by 367
Self-citationGenome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2
Ellinghaus, E., Ellinghaus, D., Stuart, P. E., Nair, R. P., Debrus, S., Raelson, J. V., Belouchi, M., Fournier, H., Reinhard, C., Ding, J., et al. (2010) · Nature Genetics · doi:10.1038/ng.689 · Cited by 359
Self-citationMease, P. J., Rahman, P., Gottlieb, A. B., Kollmeier, A. P., Hsia, E. C., Xu, X. L., Sheng, S., Agarwal, P., Zhou, B., Zhuang, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30263-4 · Cited by 355
Self-citationPsoriatic arthritis: state of the art review
Coates, L. C., & Helliwell, P. S. (2017) · Clinical Medicine · doi:10.7861/clinmedicine.17-1-65 · Cited by 353
Self-citationMcInnes, I. B., Sieper, J., Braun, J., Emery, P., van der Heijde, D., Isaacs, J. D., Dahmen, G., Wollenhaupt, J., Schulze-Koops, H., Kogan, J., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202646 · Cited by 343
Mease, P. J. (2011) · Arthritis Care & Research · doi:10.1002/acr.20577 · Cited by 342
Self-citationCo-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany
Augustin, M., Reich, K., Glaeske, G., Schaefer, I., & Radtke, M. (2010) · Acta Dermato Venereologica · doi:10.2340/00015555-0770 · Cited by 337
Molecular Dissection of Psoriasis: Integrating Genetics and Biology
Elder, J. T., Bruce, A. T., Gudjonsson, J. E., Johnston, A., Stuart, P. E., Tejasvi, T., Voorhees, J. J., Abecasis, G. R., & Nair, R. P. (2010) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.319 · Cited by 320
Danlos, F.-X., Voisin, A.-L., Dyevre, V., Michot, J.-M., Routier, E., Taillade, L., Champiat, S., Aspeslagh, S., Haroche, J., Albiges, L., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2017.12.008 · Cited by 300
Trial of Upadacitinib and Adalimumab for Psoriatic Arthritis
McInnes, I. B., Anderson, J. K., Magrey, M., Merola, J. F., Liu, Y., Kishimoto, M., Jeka, S., Pacheco-Tena, C., Wang, X., Chen, L., et al. (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2022516 · Cited by 312
Mease, P., van der Heijde, D., Landewé, R., Mpofu, S., Rahman, P., Tahir, H., Singhal, A., Boettcher, E., Navarra, S., Meiser, K., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-212687 · Cited by 303
Self-citationMease, P., Genovese, M. C., Gladstein, G., Kivitz, A. J., Ritchlin, C., Tak, P. P., Wollenhaupt, J., Bahary, O., Becker, J., Kelly, S., et al. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30176 · Cited by 300
Self-citationMenon, B., Gullick, N. J., Walter, G. J., Rajasekhar, M., Garrood, T., Evans, H. G., Taams, L. S., & Kirkham, B. W. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38376 · Cited by 293
McInnes, I. B., Behrens, F., Mease, P. J., Kavanaugh, A., Ritchlin, C., Nash, P., Masmitja, J. G., Goupille, P., Korotaeva, T., Gottlieb, A. B., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30564-x · Cited by 279
Self-citationMease, P. J., & Armstrong, A. W. (2014) · Drugs · doi:10.1007/s40265-014-0191-y · Cited by 271
Self-citationInterleukin‐17–positive mast cells contribute to synovial inflammation in spondylarthritis
Noordenbos, T., Yeremenko, N., Gofita, I., van de Sande, M., Tak, P. P., Caňete, J. D., & Baeten, D. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33396 · Cited by 270
Orbai, A.-M., de Wit, M., Mease, P., Shea, J. A., Gossec, L., Leung, Y. Y., Tillett, W., Elmamoun, M., Callis Duffin, K., Campbell, W., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2016-210242 · Cited by 268
Self-citationKenna, T. J., Davidson, S. I., Duan, R., Bradbury, L. A., McFarlane, J., Smith, M., Weedon, H., Street, S., Thomas, R., Thomas, G. P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33507 · Cited by 262
Synovial tissue hypoxia and inflammation in vivo
Ng, C. T., Biniecka, M., Kennedy, A., McCormick, J., FitzGerald, O., Bresnihan, B., Buggy, D., Taylor, C. T., O'Sullivan, J., Fearon, U., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119776 · Cited by 254
Th17 and Th22 cells in psoriatic arthritis and psoriasis
Benham, H., Norris, P., Goodall, J., Wechalekar, M. D., FitzGerald, O., Szentpetery, A., Smith, M., Thomas, R., & Gaston, H. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4317 · Cited by 253
Depression and anxiety in psoriatic disease: prevalence and associated factors
McDonough, E., Ayearst, R., Eder, L., Chandran, V., Rosen, C. F., Thavaneswaran, A., & Gladman, D. D. (2014) · The Journal of Rheumatology · doi:10.3899/jrheum.130797 · Cited by 250
Non-alcoholic fatty liver disease in patients with chronic plaque psoriasis
Gisondi, P., Targher, G., Zoppini, G., & Girolomoni, G. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.04.020 · Cited by 225
Knitza, J., Simon, D., Lambrecht, A., Raab, C., Tascilar, K., Hagen, M., Kleyer, A., Bayat, S., Derungs, A., Amft, O., et al. (2020) · JMIR mHealth and uHealth · doi:10.2196/19661 · Cited by 201
Mease, P., Coates, L. C., Helliwell, P. S., Stanislavchuk, M., Rychlewska-Hanczewska, A., Dudek, A., Abi-Saab, W., Tasset, C., Meuleners, L., Harrison, P., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32483-8 · Cited by 196
Self-citationBig Data and Clinicians: A Review on the State of the Science
Wang, W., & Krishnan, E. (2014) · JMIR Medical Informatics · doi:10.2196/medinform.2913 · Cited by 158
Mitochondrial mutagenesis correlates with the local inflammatory environment in arthritis
Harty, L. C., Biniecka, M., O'Sullivan, J., Fox, E., Mulhall, K., Veale, D. J., & Fearon, U. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200245 · Cited by 94
Serum-based soluble markers differentiate psoriatic arthritis from osteoarthritis
Chandran, V., Abji, F., Perruccio, A. V., Gandhi, R., Li, S., Cook, R. J., & Gladman, D. D. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214737 · Cited by 48
Self-citationWade, S. M., Trenkmann, M., McGarry, T., Canavan, M., Marzaioli, V., Wade, S. C., Veale, D. J., & Fearon, U. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.08.008 · Cited by 35
JAK inhibition for treatment of psoriatic arthritis in Down syndrome
Pham, A. T., Rachubinski, A. L., Enriquez-Estrada, B., Worek, K., Griffith, M., & Espinosa, J. M. (2021) · Rheumatology · doi:10.1093/rheumatology/keab203 · Cited by 32
Li, Q., Patrick, M. T., Sreeskandarajan, S., Kang, J., Kahlenberg, J. M., Gudjonsson, J. E., He, Z., & Tsoi, L. C. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1309549 · Cited by 22
Sozzani, S., Abbracchio, M. P., Annese, V., Danese, S., De Pità, O., De Sarro, G., Maione, S., Olivieri, I., Parodi, A., & Sarzi-Puttini, P. (2014) · Autoimmunity · doi:10.3109/08916934.2014.897333 · Cited by 22
Waszczykowski, M., Fabiś-Strobin, A., Bednarski, I., Lesiak, A., Narbutt, J., & Fabiś, J. (2020) · Diagnostics · doi:10.3390/diagnostics11010052 · Cited by 9
Metadata
- Authors
- Taylor, W., Gladman, D., Helliwell, P., Marchesoni, A., Mease, P., & Mielants, H.
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2006-07-26
- Volume
- 54
- Issue
- 8
- Pages
- 2665-2673
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2083180635
- Cited by
- 3,746
- References
- 15
- FWCI
- 41.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.